TY - JOUR
T1 - Online Abortion Drug Sales in Indonesia
T2 - A Quality of Care Assessment
AU - Moore, Ann M.
AU - Philbin, Jesse
AU - Ariawan, Iwan
AU - Budiharsana, Meiwita
AU - Murro, Rachel
AU - Aryanty, Riznawaty Imma
AU - Bankole, Akinrinola
N1 - Funding Information:
The authors would like to thank the members of the advisory committee for their guidance throughout the duration of the study: Prof. Dr. Saparinah Sadli, Chairperson (University of Indonesia), Rita Kalibonso (Mitra Perempuan), Prof. Budi Utomo (University of Indonesia), Atashendartini Habsjah (PKBI), Dr. Marcia Soumokil (Ipas), Ika Ayu Kristianingrum (Samsara Jogjakarta), and Amalia Puri Handayani (Women on Web). The authors would also like to acknowledge Geby Hasanah Jorgy and Zahra Izza Arifa (both of Reconstra) for their research contributions; the mystery clients Ranna Adilla, Isna Oktafia, Fransiska Lusiani, the fieldwork supervisor Ester Novalia Tambunan and the pharmacist Mutia Nuriani who carried out the drug identifications; Nakeisha Blades and Onikepe Owolabi (the Guttmacher Institute) for their help on the study tool; Ann Biddlecom, Adesegun Fatusi, Onikepe Owolabi, Margaret Giorgio, Zara Ahmed, and Aisha Akhter (of the Guttmacher Institute), and Amanda Stevenson and Elizabeth Raymond for helping us during the course of making early design decisions. This study benefitted from input from a larger three‐country study team, including staff from Guttmacher Institute, Academy for Health Development (AHEAD, Nigeria), Centre for Research, Evaluation Resources and Development (CRERD, Nigeria), Oriéntame (Colombia), and Reconstra (Indonesia). This work was supported by UK Aid from the UK Government under Grant 203177‐101, the Dutch Ministry of Foreign Affairs under Grant 4000000282, and an anonymous foundation.
Funding Information:
The authors would like to thank the members of the advisory committee for their guidance throughout the duration of the study: Prof. Dr. Saparinah Sadli, Chairperson (University of Indonesia), Rita Kalibonso (Mitra Perempuan), Prof. Budi Utomo (University of Indonesia), Atashendartini Habsjah (PKBI), Dr. Marcia Soumokil (Ipas), Ika Ayu Kristianingrum (Samsara Jogjakarta), and Amalia Puri Handayani (Women on Web). The authors would also like to acknowledge Geby Hasanah Jorgy and Zahra Izza Arifa (both of Reconstra) for their research contributions; the mystery clients Ranna Adilla, Isna Oktafia, Fransiska Lusiani, the fieldwork supervisor Ester Novalia Tambunan and the pharmacist Mutia Nuriani who carried out the drug identifications; Nakeisha Blades and Onikepe Owolabi (the Guttmacher Institute) for their help on the study tool; Ann Biddlecom, Adesegun Fatusi, Onikepe Owolabi, Margaret Giorgio, Zara Ahmed, and Aisha Akhter (of the Guttmacher Institute), and Amanda Stevenson and Elizabeth Raymond for helping us during the course of making early design decisions. This study benefitted from input from a larger three-country study team, including staff from Guttmacher Institute, Academy for Health Development (AHEAD, Nigeria), Centre for Research, Evaluation Resources and Development (CRERD, Nigeria), Ori?ntame (Colombia), and Reconstra (Indonesia). This work was supported by UK Aid from the UK Government under Grant 203177-101, the Dutch Ministry of Foreign Affairs under Grant 4000000282, and an anonymous foundation.
Publisher Copyright:
© 2020 The Authors. Studies in Family Planning published by Wiley Periodicals LLC on behalf of Population Council
PY - 2020/12
Y1 - 2020/12
N2 - This study sought to understand the experience of buying misoprostol online for pregnancy termination in Indonesia. We conducted a mystery client study August through October, 2019. Interactions were analyzed quantitatively and qualitatively, along with the contents of the packages. One hundred ten sellers were contacted, from whom mystery clients made 76 purchases and received 64 drug packages. Almost all sellers sold “packets” containing multiple drugs; 73 percent of packets contained misoprostol, and 47 percent contained at least 800 mcg of misoprostol. Thirty-four packets contained insufficient drugs to complete an abortion. When compared to WHO standards, 87 percent of sellers imparted incomplete information about potential physical effects; no seller provided information about possible complications. Women buying misoprostol from informal online drugs sellers will be underprepared for understanding potential side effects and complications. Educational activities are needed to increase women's access to information about safe use of misoprostol as a harm reduction strategy.
AB - This study sought to understand the experience of buying misoprostol online for pregnancy termination in Indonesia. We conducted a mystery client study August through October, 2019. Interactions were analyzed quantitatively and qualitatively, along with the contents of the packages. One hundred ten sellers were contacted, from whom mystery clients made 76 purchases and received 64 drug packages. Almost all sellers sold “packets” containing multiple drugs; 73 percent of packets contained misoprostol, and 47 percent contained at least 800 mcg of misoprostol. Thirty-four packets contained insufficient drugs to complete an abortion. When compared to WHO standards, 87 percent of sellers imparted incomplete information about potential physical effects; no seller provided information about possible complications. Women buying misoprostol from informal online drugs sellers will be underprepared for understanding potential side effects and complications. Educational activities are needed to increase women's access to information about safe use of misoprostol as a harm reduction strategy.
KW - abortion drug protocols offered by online seller
KW - online mystery client study
KW - self-managed abortion
UR - http://www.scopus.com/inward/record.url?scp=85092722592&partnerID=8YFLogxK
U2 - 10.1111/sifp.12138
DO - 10.1111/sifp.12138
M3 - Article
AN - SCOPUS:85092722592
SN - 0039-3665
VL - 51
SP - 295
EP - 308
JO - Studies in Family Planning
JF - Studies in Family Planning
IS - 4
ER -